n-succinimidyl 3-(2-pyridyldithio)propionate has been researched along with Sarcoma 180 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chu, SC; Hsieh, YS; Lin, JY | 1 |
1 other study(ies) available for n-succinimidyl 3-(2-pyridyldithio)propionate and Sarcoma 180
Article | Year |
---|---|
Chimeric protein: abrin B chain-trypsin inhibitor conjugate as a new antitumor agent.
Topics: Abrin; Animals; Antineoplastic Agents, Phytogenic; Cell Division; Cross-Linking Reagents; HeLa Cells; Humans; Male; Mice; Plant Proteins; Sarcoma 180; Succinimides; Trypsin Inhibitors; Tumor Cells, Cultured | 1989 |